Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. European Lung Cancer Congress 2024
  5. Satellite Symposia Webcasts

Pfizer Oncology - Shaping the future of ALK+ NSCLC: What’s the next leap forward?

Evolution of the 1L ALK+ NSCLC treatment landscape

Date

21 Mar 2024

Session

Pfizer Oncology - Shaping the future of ALK+ NSCLC: What’s the next leap forward?

Presenters

Giulia Pasello

Authors

G. Pasello

Author affiliations

  • Università degli Studi di Padova, Padova/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Solange Peters

Session: Pfizer Oncology - Shaping the future of ALK+ NSCLC: What’s the next leap forward?

Resources:

Webcast

Optimising patient outcomes

Presenter: Jessica Lin

Session: Pfizer Oncology - Shaping the future of ALK+ NSCLC: What’s the next leap forward?

Resources:

Webcast

Meeting close

Presenter: Solange Peters

Session: Pfizer Oncology - Shaping the future of ALK+ NSCLC: What’s the next leap forward?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.